Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

Co-Diagnostics, Inc. Stock Price·Forecast · AI Analysis | StockRay

Co-Diagnostics, Inc.

CODX · Healthcare · $6M

After-hours $1.070.00%

2026 Q2 earnings

Price

$3.10

$1.11

Jun 30, 26Sep 28, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$0M+1.7%

6/'26 vs prev quarter

Company Health

Market Cap$6M

Operating Margin-4170.1%

Cash on Hand$4M56.6% of market cap

Among 326 Biotechnology peers

LowMedianHigh

PSR1.7x

median 11.1xPBR0.1x

median 2.0xROE-370.2%

median -54.5%

Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in FloridaSep 10

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in IndiaSep 3

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF BaseSep 1

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media EventAug 18

Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call TranscriptAug 13

Co-Diagnostics Reports Second Quarter 2026 Financial ResultsAug 13

Related Stocks

A
Alzamend Neuro Inc
B
Bolt Biotherapeutics, Inc.
A
Aclarion, Inc.
A
AIM ImmunoTech Inc.
E
Enveric Biosciences, Inc.
E
Ensysce Biosciences, Inc.
F
Femasys Inc.
e
enVVeno Medical Corporation

Daily Prices

09.28$1.11-3.60%

09.25$1.09-5.22%

09.24$1.15+4.55%

09.23$1.10+1.85%

09.22$1.08+6.93%

09.21$1.01+6.80%

09.18$0.95+0.57%

09.17$0.94-0.05%

09.16$0.94-17.47%

09.11$1.12+1.82%

Quarterly Revenue Growth

PriorCurrent

25년 9월25년 12월26년 3월26년 6월26년 9월Est.

Revenue Breakdown

As of Dec 2025

Source: Company IR filings

Product67.2%
Grant32.8%

BusinessBiotechnology·co-dx.com↗

“매출은 16만6천 달러로 전 분기 14만6천 달러에서 반등했지만, 전 분기보다 26만4천 달러였던 지난해 4분기 수준에는 못 미쳐 아직 상업화”

In the company's words · 2026 2분기 earnings call